Home
Senores Pharmaceuticals Ltd Quarterly Result

Senores Pharmaceuticals Ltd
NSE: SENORES
Net Profit - Last Quarter
Senores Pharmaceuticals Ltd Quarterly Results Key Highlights
- The revenue of Senores Pharmaceuticals Ltd for the Dec '24 is ₹ 108.18 crore as compare to the Mar '24 revenue of ₹ 104.4 crore.
- This represent the growth of 3.62%a1# The ebitda of Senores Pharmaceuticals Ltd for the Dec '24 is ₹ 30.85 crore as compare to the Mar '24 ebitda of ₹ 24.35 crore.
- This represent the growth of 26.69%a1# The net profit of Senores Pharmaceuticals Ltd for the Dec '24 is ₹ 16.43 crore as compare to the Mar '24 net profit of ₹ 14.18 crore.
- This represent the growth of 15.87%a1#.
Senores Pharmaceuticals Ltd Quarterly Results Analysis
Market Price of Senores Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
12 Mar 2025 | 576.35 |
11 Mar 2025 | 551.2 |
10 Mar 2025 | 548.75 |
07 Mar 2025 | 566.1 |
06 Mar 2025 | 593.75 |
05 Mar 2025 | 596.1 |
04 Mar 2025 | 562.2 |
03 Mar 2025 | 530.4 |
28 Feb 2025 | 543.75 |
27 Feb 2025 | 566.7 |
Historical Revenue of Senores Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Senores Pharmaceuticals Ltd
Historical EBITDA of Senores Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Senores Pharmaceuticals Ltd
Historical Net Profit of Senores Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Senores Pharmaceuticals Ltd
Senores Pharmaceuticals Ltd News Hub
Senores Pharma spurts as PAT jumps to Rs 16 cr in Q3 FY25
Profit before tax stood at Rs 20.48 crore in the December 2024 quarter, up 99.61% from Rs 10.26 cror
Read more
23 Jan 25
Senores Pharma gets final approval for Metoprolol Tartrate and Hydrochlorothiazide tablets
Metoprolol Tartrate and Hydrochlorothiazide Tablet is the combination tablet of metoprolol tartrate,
Read more
10 Jan 25
Senores Pharmaceuticals IPO subscribed 93.41 times
The initial public offer (IPO) of Senores Pharmaceuticals received bids for 79,72,30,918 shares as a
Read more
24 Dec 24
Senores Pharmaceuticals receives USFDA approval for Metoprolol Tartrate and Hydrochlorothiazide Tablet
Senores Pharmaceuticals has received final approval from the United States Food and Drug Administrat
Read more
10 Jan 25